Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19

NCT04344457 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine
DRUG: Indomethacin
DRUG: Zithromax Oral Product

Sponsor

Perseverance Research Center, LLC

Collaborators

[object Object]